Abstract B26: MiR-200 is involved in anti-invasive activity of sulindac in colon cancer

This study is supported by the NIH/NCI R01 Grant (1R01CA192395) and the American Cancer Society Research Scholar Grant (RSG-13-265-01-RMC).Citation Format: Hong Chang, Xiangling Feng, Ruixia Ma, Yaguang Xi. MiR-200 is involved in anti-invasive activity of sulindac in colon cancer. [abstract]. In: Proceedings of the AACR Precision Medicine Series: Cancer Cell Cycle - Tumor Progression and Therapeutic Response; Feb 28-Mar 2, 2016; Orlando, FL. Philadelphia (PA): AACR; Mol Cancer Res 2016;14(11_Suppl):Abstract nr B26.

Source: Molecular Cancer Research - November 9, 2016 Category: Cancer & Oncology Authors: Chang, H., Feng, X., Ma, R., Xi, Y. Tags: Other Topics: Poster Presentations - Proffered Abstracts Source Type: research